Tag:
MPM Capital
Latest Headlines
Latest Headlines
VC: Alder raises $40M
Alder raises $40M VENTURE CAPITALCOMPANY AMOUNT/ROUNDLEAD INVESTORSDESCRIPTION Alder Biopharmaceuticals Bothell, WA$40MThirdDelphi Ventures and
PeptImmune land $8.2M in series D
Cambridge, MA-based PeptImmune has garnered $8.2 million in a fourth round of funding. New Enterprise Associates, MPM Capital, Hunt Ventures L.P., Boston Medical Investors and Silicon Valley Bank
SPOTLIGHT: Xanodyne files IPO
After garnering a total of $232 million in venture funds to buy aaiPharma's pharmaceutical division out of bankruptcy, Xanodyne Pharmaceuticals--which has three products in development in addition
Seattle start-up gains $30M in second venture round
Another biotech graduate of the Seattle incubator Accelerator Corp. has won a significant round of venture backing. Allozyne says that it has garnered a $30 million Series B, enough money to take a
VC: Neuromed lands $53.3M in fifth round
Neuromed lands $53.3M in fifth round VENTURE CAPITAL COMPANY AMOUNT/ROUND LEAD INVESTORS DESCRIPTION Neuromed
Neuromed banks $53.3M in venture funds
Neuromed Pharmaceuticals has garnered a whopping $53.3 million in Series E funds, bringing its total take in venture capital to $126 million. Much of that money is earmarked for clinical trials,
KaloBios gains $20M in third round
KaloBios Pharmaceuticals has garnered $20 million in its third round, with much of that earmarked to advance its clinical development work. Lehman Brothers led the round with MPM Capital, Sofinnova
Press Release: Elixir Pharmaceuticals Raises $46 Million
Press Release: Elixir Pharmaceuticals Raises $46 Million
VC: Santaris leads with a $48.3M round
Santaris leads with a $48.3M round
Santaris Pharma pockets $48.3M in VC
Denmark's Santaris Pharma has raised $48.3 million in venture funds. ABN AMRO Capital Life Sciences of the Netherlands led the round. Santaris has specialized in developing RNA Antagonist drugs based on Locked Nucleic Acid.
- here's the release
PLUS: Helicos BioSciences, which specializes in high-speed, high-sensitivity DNA sequencing, has garnered $40 million in new venture funds. The …
